KORU Medical Systems (KRMD) EBIT (2010 - 2026)

KORU Medical Systems (KRMD) has 12 years of EBIT data on file, last reported at -$864923.0 in Q1 2026.

• On a quarterly basis, EBIT rose 30.53% year-over-year to -$864923.0 in Q1 2026; TTM through Mar 2026 was -$2.6 million, a 54.76% increase from a year earlier, with the FY2025 full-year figure at -$3.0 million, up 53.89% from the prior year.
• EBIT for Q1 2026 stood at -$864923.0, down from -$547104.0 in the prior quarter.
• Over the last five years, EBIT for KRMD reached as high as -$312655.0 in Q2 2025 and fell as low as -$3.6 million in Q2 2022.
• Historically, EBIT has averaged -$1.8 million across 5 years, with a median of -$1.7 million in 2024.
• Across the five-year window, EBIT slumped 161.65% in 2022 and jumped 73.77% in 2025, its largest moves.
• Year by year, EBIT stood at -$2.5 million in 2022, then rose by 12.5% to -$2.2 million in 2023, then rose by 27.67% to -$1.6 million in 2024, then soared by 65.58% to -$547104.0 in 2025, then slumped by 58.09% to -$864923.0 in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$864923.0 in Q1 2026, -$547104.0 in Q4 2025, and -$867679.0 in Q3 2025.